What is NDC 70771-1676?

70771-1676 is the product NDC for Lenalidomide, Lenalidomide 2.5 mg/1 capsule, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lenalidomide?

107 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lenalidomide NDC 70771-1676 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1676Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1676Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1676-1	7077116760170771167601	100 CAPSULE in 1 BOTTLE (70771-1676-1)Marketed from Mar 7, 2023
70771-1676-7	7077116760770771167607	28 CAPSULE in 1 BOTTLE (70771-1676-7)Marketed from Mar 7, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lenalidomide
Generic name (nonproprietary): lenalidomide
Active ingredients: Lenalidomide — 2.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210154
Marketing start: Mar 7, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 70771-1676_b85844ee-03a3-407f-97a9-ae0098212923SPL ID b85844ee-03a3-407f-97a9-ae0098212923SPL set ID fd23328f-b019-4c14-80d9-4ebd997f26b2RxCUI 602910, 602912, 643712, 643720, 1242231, 1428947UNII F0P408N6V4
Pharmacologic class: Thalidomide Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771167601 followed by a unit qualifier and the quantity

Package 70771-1676-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1676

What is NDC 70771-1676?: 70771-1676 is the product NDC for Lenalidomide, Lenalidomide 2.5 mg/1 capsule, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lenalidomide.
What is the active ingredient?: Lenalidomide.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lenalidomide?: 107 other product NDCs are listed under this name. See all Lenalidomide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lenalidomide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-692	16729-0692-09
Lenalidomide	Lenalidomide 25 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-697	16729-0697-06
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-695	16729-0695-06
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-693	16729-0693-09
Lenalidomide	Lenalidomide 20 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-696	16729-0696-06
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-694	16729-0694-09
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Padagis US LLC	0574-1402	00574-1402-28
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Padagis US LLC	0574-1405	00574-1405-28
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Padagis US LLC	0574-1410	00574-1410-28
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Padagis US LLC	0574-1415	00574-1415-21

All 108 Lenalidomide NDCs

Other NDCs under ANDA 210154

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210154
Product	Strength	Form · route	Labeler	Product NDC
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1030
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1031
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1032
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1033
Lenalidomide	Lenalidomide 20 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1034
Lenalidomide	Lenalidomide 25 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1035
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1677
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1678
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1679
Lenalidomide	Lenalidomide 20 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1680
Lenalidomide	Lenalidomide 25 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1681